Indication
Antibody
3 clinical trials
3 products
Clinical trial
Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer TreatmentStatus: Recruiting, Estimated PCD: 2026-12-08
Product
COVID-19 Booster VaccineClinical trial
Randomized, Blind and Positive Control Design: a Phase III Clinical Trial to Evaluate the Consistency Between Batches of 5 Doses of Freeze-dried Rabies Vaccine (Vero Cell) and the Immunogenicity and Safety of 4 Doses of Vaccine (1-1-1-1)Status: , Estimated PCD: 2024-05-30
Product
Immunization proceduresClinical trial
Intra-tumor Delivery of Double Checkpoint Inhibitors, Chemodrug, and/or Bevacizumab Therapy as First Line for Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2030-12-30
Product
Ipilimumab + Pembrolizumab